Earnings Conference Call to be held on March 13, 2008 at 9:00 am (Eastern)
/ 6:00 am (Pacific) / 9:00 pm (Beijing/Hong Kong)
SHANGHAI, China, Feb. 21 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech" or "the Company"), the leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will release unaudited financial results for the fourth quarter and full year ended December 31, 2007 after the US market close on Wednesday, March 12, 2008.
The earnings release will be available on the investor relations page of its website at http://www.wuxipharmatech.com .
Following the earnings announcement, WuXi PharmaTech senior management
will host a conference call at 9:00 am (Eastern) / 6:00 am (Pacific) / 9:00
pm (Beijing/Hong Kong) on Thursday, March 13, 2008 to discuss its 2007
fourth quarter and full year financial results and recent business
activity. The conference call may be accessed by calling:
Toll Free: +1-888-596-2633
China, Northern Region
Toll Free: +10-800-714-0970
China, Southern Region
Toll Free: +10-800-140-0945
Toll Free: +800-965-503
Toll Free: +0808-101-1402
A telephone replay will be available shortly after the call until April 12, 2008 at (US) +1-888-203-1112/ (HK) +800-901-108 / (China, Southern Region) +10-800-140-1178 / (China, Northern Region) +1-719-457-0820 / (UK) +0808-101- 1153. Passcode: 2224172.
A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxipharmatech.com .
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech, headquartered in Shanghai, China, is the leading
global pharmaceutical, biotechnology and medical device R&D outsourcing
company. As a research-driven and customer-focused company, WuXi PharmaTech
provides pharmaceutical, biotechnology and medical device companies a broad
and integrated portfolio of laboratory, research manufacturing, biologics
testing and manufacturing services throughout the drug and medical device
research and development process. WuXi PharmaTech's services are designed
to assist its global partners in shortening the cycle and lowering the cost
of drug and medical device research and development by providing
cost-effective and efficient outsourcing solutions that save its customers
both time and money. For more information, please visit:
For more information, please contact:
Dr. Hai Mi, Vice President, Corporate Communications
WuXi PharmaTech Co., Ltd
Investor Relations (US):
Mahmoud Siddig, Director
Investor Relations (HK):
Ruby Yim, Managing Director
|SOURCE WuXi PharmaTech (Cayman) Inc.|
Copyright©2008 PR Newswire.
All rights reserved